Lingli He

Lingli He

Auto-generated profile, based on publicly available information

Lingli He

State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Innovation Center for Cell Signaling Network, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, 200031, P.R. China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in Cancer Research
Verified
Journal Article
Closed access
PDF file
LHLingli He
Lingli He
LYLiang Yuan
Liang Yuan
YSYang Sun
Yang Sun
PWPingyang Wang
Pingyang Wang
HZHailin Zhang
Hailin Zhang
LZLei Zhang
Lei Zhang
The Hippo pathway plays a critical role in cell growth and tumorigenesis. The activity of TEA domain transcription factor 4 (TEAD4) determines the output of Hippo signaling; however, the regulation and function of TEAD4 has not been explored extensively. Here, we identified glucocorticoids (GC) as novel activators of TEAD4. GC treatment facilitated glucocorticoid receptor (GR)-dependent nuclear accumulation and transcriptional activation of TEAD4. TEAD4 positively correlated with GR expression in human breast cancer, and high expression of TEAD4 predicted poor survival of patients with breast cancer. Mechanistically, GC activation promoted GR interaction with TEAD4, forming a complex that was recruited to the TEAD4 promoter to boost its own expression. Functionally, the activation of TEAD4 by GC promoted breast cancer stem cells maintenance, cell survival, metastasis, and chemoresistance both in vitro and in vivo. Pharmacologic inhibition of TEAD4 inhibited GC-induced breast cancer chemoresistance. In conclusion, our study reveals a novel regulation and functional role of TEAD4 in breast cancer and proposes a potential new strategy for breast cancer therapy. Significance: This study provides new insight into the role of glucocorticoid signaling in breast cancer, with potential for clinical translation.

22 July 2019 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
XFXue Feng
Xue Feng
ZWZuoyun Wang
Zuoyun Wang
FWFei Wang
Fei Wang
TLTiantian Lu
Tiantian Lu
JXJinjin Xu
Jinjin Xu
LZLei Zhang
Lei Zhang
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 November 2018 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
WZWenxiang Zhang
Wenxiang Zhang
JXJinjin Xu
Jinjin Xu
JLJinhui Li
Jinhui Li
TGTong Guo
Tong Guo
DJDan Jiang
Dan Jiang
LZLei Zhang
Lei Zhang
The Hippo signaling pathway is known to play an important role in multiple physiological processes, including adipogenesis. However, whether the downstream components of the Hippo pathway are involved in adipogenesis remains unknown. Here we demonstrate that the TEA domain family (TEAD) transcription factors are essential for adipogenesis in murine 3T3-L1 preadipocytes. Knockdown of TEAD1–4 stimulated adipogenesis and increased the expression of adipocyte markers in these cells. Interestingly, we found that the TEAD4 knockdown–mediated adipogenesis proceeded in a Yes-associated protein (YAP)/TAZ (Wwtr1)–independent manner and that adipogenesis suppression in WT cells involved formation of a ternary complex comprising TEAD4 and the transcriptional cofactors C-terminal binding protein 2 (CtBP2) and vestigial-like family member 4 (VGLL4). VGLL4 acted as an adaptor protein that enhanced the interaction between TEAD4 and CtBP2, and this TEAD4–VGLL4–CtBP2 ternary complex dynamically existed at the early stage of adipogenesis. Finally, we verified that TEAD4 directly targets the promoters of major adipogenesis transcription factors such as peroxisome proliferator–activated receptor γ (PPARγ) and adiponectin, C1Q, and collagen domain–containing (Adipoq) during adipogenesis. These findings reveal critical insights into the role of the TEAD4–VGLL4–CtBP2 transcriptional repressor complex in suppression of adipogenesis in murine preadipocytes.

9 January 2015 in Molecular Medicine Reports
Verified
Journal Article
Closed access
PDF file
XFXiang Fan
Xiang Fan
LHLingli He
Lingli He
YMYao Meng
Yao Meng
GLGangrui Li
Gangrui Li
LLLinli Li
Linli Li
YMYanfa Meng
Yanfa Meng
α‑Momorcharin (α‑MMC) and momordica anti‑human immunodeficiency virus protein (MAP30), produced by Momordica charantia, are ribosome‑inactivating proteins, which have been reported to exert inhibitory effects on cultured tumor cells. In order to further elucidate the functions of these agents, the present study aimed to investigate the effects of α‑MMC and MAP30 on cell viability, the induction of apoptosis, cell cycle arrest, DNA integrity and superoxide dismutase (SOD) activity. α‑MMC and MAP30 were purified from bitter melon seeds using ammonium sulfate precipitation in combination with sulfopropyl (SP)‑sepharose fast flow, sephacryl S‑100 and macro‑Cap‑SP chromatography. MTT, flow cytometric and DNA fragmentation analyses were then used to determine the effects of α‑MMC and MAP30 on human lung adenocarcinoma epithelial A549 cells. The results revealed that A549 cells were sensitive to α‑MMC and MAP30 cytotoxicity assays in vitro. Cell proliferation was significantly suppressed following α‑MMC and MAP30 treatment in a dose‑ and time‑dependent manner; in addition, the results indicated that MAP30 had a more potent anti‑tumor activity compared with that of α‑MMC. Cell cycle arrest in S phase and a significantly increased apoptotic rate were observed following treatment with α‑MMC and MAP30. Furthermore, DNA integrity analysis revealed that the DNA of A549 cells was degraded following treatment with α‑MMC and MAP30 for 48 h. The pyrogallol autoxidation method and nitrotetrazolium blue chloride staining were used to determine SOD activity, the results of which indicated that α‑MMC and MAP30 did not possess SOD activity. In conclusion, the results of the present study indicated that α‑MMC and MAP30 may have potential as novel therapeutic agents for the prophylaxis and treatment of cancer.

7 January 2020 in Nanoscale
Verified
Journal Article
Closed access
PDF file
JGJing Gao
Jing Gao
LHLingli He
Lingli He
LZLulu Zhou
Lulu Zhou
YJYingying Jing
Yingying Jing
FWFeng Wang
Feng Wang
HWHongda Wang
Hongda Wang
Our work uncovers the role of GPCRs and F-actin in pressure-controlled YAP inactivation, and provides new insights into the mechanisms of mechanical regulation to the Hippo signaling pathway.

13 October 2017 in Nanoscale
Verified
Journal Article
Closed access
PDF file
JGJing Gao
Jing Gao
LHLingli He
Lingli He
YSYan Shi
Yan Shi
MCMingjun Cai
Mingjun Cai
HXHaijiao Xu
Haijiao Xu
HWHongda Wang
Hongda Wang
Super-resolution imaging combined with biochemical methods revealed the regulation of cell contact and pressure on YAP localization, phosphorylation and clustering.